Drug Importation in New Mexico: An Overview

new-mexico-map-importation-danger

Synopsis:

In March 2020, the Governor of New Mexico signed SB1, a bill which creates a "wholesale prescription drug importation program" to be administered by New Mexico's Department of Health. The bill requires that New Mexico submit a plan to the U.S. Department of Health and Human Services in December 2020.

Current status:

New Mexico is developing a plan to submit to the U.S. Secretary of Health and Human Services for approval by December 15, 2020.

How should we evaluate this program?

The program hasn't started yet so there's no way to measure whether it saved money or kept patients safe, both promises made at the time of passage. However, the 2003 Medicare Modernization Act contains requirements for safety requirements built into any such program.

Official actions and statements

Planning documents

Op-eds from the Experts

Canadian Physician Warns that American Drug Importation is Bad for Canada

August 13, 2019

This editorial by Dr. Charles S. Shaver was published in The Hamilton Spectator on August 11, 2019. Dr. Shaver i a practicing physician in Ottawa. He is a graduate of Princeton University and Johns Hopkins School of Medicine. Dr. Shaver is also past chair of the section on general internal medicine of the Ontario Medical Association.

Economist Warns that Federal Drug Importation is Folly

August 7, 2019

This editorial by Wayne Winegarden, Ph.D. appeared in Forbes on August 7, 2019. Dr. Winegarden is the Managing Editor for EconoSTATS and a senior Fellow in Business and Economics at the Pacific Research Institute.

Policy Expert: “Even if Canada were a willing participant, the U.S. can’t ensure the safety of these drugs.”

August 7, 2019

In this editorial, which was published in The Washington Examiner on August 5, 2019, Pacific Research Institute CEO Sally Pipes explains that ” importing prescription drugs would put our lives in danger.”

Importation Won’t Save Money, warn Citizens Against Government Waste

August 2, 2019

In this July 31, 2019 blog post on the Citizens Against Government Waste (CAGW) website, CAGW Director of Health and Science Policy Elizabeth Wright questions the questions the effectiveness and safety of government importation schemes.

Florida State Senator Compares Supporting Drug Importation to Believing in the Tooth Fairy

July 17, 2019

This editorial by Perry Thurston Jr. was published in Florida Politics on July 16, 2019. In it, State Senator Thurston explains that state-implemented drug importation will not bring any medication cost savings to Floridians.

Drug Distribution Experts Warn That State Plans To Import Foreign Drugs Will Undermine Safety

July 11, 2019

This editorial by Adam Fein and Dirk Rodgers was published in Stat News on July 11, 2019. In it, Fein and Rodgers warn that plans by states to create drug importation programs will open new pathways for counterfeit drugs to enter the U.S. drug supply chain…

Kentucky State Legislator Warns That Counterfeit Fentanyl Pills Are Killing Americans

July 2, 2019

This editorial by Kentucky State Representative Sal Santoro was published in Kentucky Today on June 27, 2019. In it, Santoro highlights the dangers of fentanyl to law enforcement officers as well as the fact that counterfeit pills made with the dangerous synthetic opioid are killing Americans across the country…

Importation Is An Opportunity For Organized Crime to Expand Counterfeit Drug Profits, DEA Veteran Says

June 28, 2019

This editorial by retired DEA agent Douglas Hebert was published in The Arizona Capital Times ,on June 27, 2019. In it, Hebert explains how drug importation programs will help organized crime expand their $200 billion-a-year counterfeit pharmaceutical industry into the U.S., at the expense of Americans.

Retired Canadian law enforcement official urges the New York Legislature: “Step Away” from dangerous drug importation proposal

June 20, 2019

In this editorial, which was published in Crain’s New York Business on June 19, 2019, Canadian law enforcement veteran Don Bell explains that the New York Legislature’s effort to establish a wholesale prescription drug importation program, is “a gigantic loophole that criminals will pounce on to traffic counterfeit drugs into the state.”

“Canada cannot act as a drugstore for the United States,” says academic

June 19, 2019

In this editorial, which was published by the Fraser Institute on June 13, 2019, economist Dr. Kristina Acri argues against importation, concluding: “Diverting drugs meant for Canadian patients to the U.S. through state importation schemes will create shortages for Canadian patients and increase pressure on potentially unscrupulous suppliers to source drugs from wherever they can, opening the door to counterfeiters.”